- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Screening
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
COVID-19 Vaccines 2024-2025: Is America Ready and Willing?
COVID-19 vaccine myths of many types remain potent enough to raise public health experts' concerns about Americans' willingness to roll up sleeves this year.
The collective American willingness to step up for a dose of the newly approved monovalent vaccine against infection with the SARS-CoV-2 virus looks as though it will be blunted for the 2024-2025 respiratory virus season. The assessment is based on survey findings published in the summer 2024 Annenberg Science and Public Health Knowledge Monitor, which tracks national levels of health knowledge and misinformation over time.
The survey queried 1496 US adults between July 11 and 18, and the results suggest that ongoing misinformation on COVID-19 vaccines continues to erode confidence in the shot's safety and efficacy.
The findings reveal that relatively few Americans are concerned about getting COVID-19 themselves or about relatives becoming infected with the virus; further, less than half are somewhat or very likely to get their COVID vaccination this year. The willingness to be vaccinated against the flu is also on the wane as is acceptance of the new RSV immunization among eligible older adults.
Click through this short slide show for a snapshot of the vaccination environment that may confront primary care professionals this fall.
